Maintenance treatment with infliximab for the management of Crohn’s disease in adults
Renato Caviglia, Ivo Boškoski, Michele CicalaDepartment of Digestive Diseases, Campus Bio-Medico University of Rome, Rome, ItalyAbstract: Crohn’s disease (CD) is a chronic, relapsing disease, the continuous cycle of which deeply affects the long-term course which, eventu...
Guardado en:
Autores principales: | Renato Caviglia, Ivo Boškoski, Michele Cicala |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f61fd76531d943099961f7fae40a8b0b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Adalimumab for the treatment of Crohn’s disease
por: Andrea Cassinotti, et al.
Publicado: (2008) -
Natalizumab in the treatment of Crohn’s disease
por: Danila Guagnozzi, et al.
Publicado: (2008) -
Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
por: Matsumoto S, et al.
Publicado: (2018) -
Management of ankylosing spondylitis with infliximab
por: Éric Toussirot, et al.
Publicado: (2009) -
Infliximab en el tratamiento de la enfermedad de Crohn: Estudio preliminar
por: Gellona V,José, et al.
Publicado: (2006)